Insamo

Insamo is a biotechnology company developing membrane-permeable and orally available cyclic-peptides. They utilize a platform combining ML-driven molecular design, high-throughput molecular biology, and parallel synthetic chemistry to rapidly identify preclinical drug candidates. This allows for the creation of oral cyclic-peptide formulations and addresses currently intractable drug targets.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $12M

Date: 21-Feb-2024

Investors: Playground Global, venBio, MRL Ventures Fund, Sahsen Ventures, BEVC, Civilization Ventures, Axial Ventures

Markets: Biotechnology, Pharmaceuticals, AI, Machine Learning, Drug Discovery, Other Healthcare Technology Systems, HealthTech

HQ: Berkeley, California, United States

Founded: 2022

Website: https://insamo.com/

LinkedIn: https://www.linkedin.com/company/insamo

Twitter:

Instagram: